Demonstration of the Antioxidant Capabilities of a Product Formulated with Antioxidants Stabilized in their Reduced Form

January 2020 | Volume 19 | Issue 1 | Original Article | 46 | Copyright © January 2020


Published online December 19, 2019

Zoe Diana Draelos , Catherine J. Pachuk

aDermatology Consulting Services, PLLC, High Point, NC, bSomahlution, Jupiter, FL

Abstract
Oxidative damage from reactive oxygen species is instrumental in aging. Topical antioxidants are used in many cosmeceuticals to provide appearance benefits; however, the activity of these antioxidants may be questionable. This research validated the activity of L-ascorbic acid and L-glutathione in the studied facial product and correlated this activity with clinical appearance improvement following 12 weeks of use.

J Drugs Dermatol. 2020;19(1):46-49. doi:10.36849/JDD.2020.3947

INTRODUCTION

The final common pathway for skin damage of all types, including aging, is the production of reactive oxygen species (ROS). Unfortunately, avoiding ROS exposure is impossible due to their extrinsic environmental abundance and intrinsic production through cellular metabolism.1 The body has developed a variety of antioxidant protective mechanisms, which may be augmented through use of exogenous antioxidant materials; however, the antioxidants must be stable and functional in cosmetic formulations. In order to be effective, antioxidants must exist in a reduced or active state since only reduced antioxidants can neutralize an oxidant.2,3 Without special manufacturing or formulation controls to stabilize antioxidants in their reduced form, antioxidants are converted to their inactive oxidized form and are no longer functional. This antioxidant capability must be maintained over the shelf life of the product, which is rarely substantiated by cosmetic manufacturers.

Many currently marketed antioxidant formulations claim to contain stabilized forms of vitamin C, such as ascorbyl-2-glucoside and magnesium ascorbyl phosphate, or stabilized forms of glutathione, such as acyl-glutathione. While these molecules are stable, they are not antioxidants. They are antioxidant-precursors that must be enzymatically modified following skin application to yield L-ascorbic acid and glutathione respectively.4,5 While conversion to functional antioxidants has been demonstrated in cell culture, where it is relatively easy to introduce large amounts of these stable precursors, conversion following topical application is an inefficient process.4 Other skin care products claim to contain antioxidant fruit or herb extracts; however, any antioxidant originally present in the fruit or herb is no longer active when the extract is prepared for addition to a cosmetic formulation. This research examined a novel antioxidant formulation of L-ascorbic acid and L-glutathione manufactured using antioxidant stabilization technology originally developed for organ/tissue preservation products. The primary cause of operating room transplant organ damage is oxidative damage. The organ preservation solution must contain active and stable antioxidants to optimize the viability of the harvested organ. Development of these solutions requires proof of the presence and stability of antioxidants prior to regulatory clearance. Manufacturing must also occur under GMP conditions. This same preservation technology has been used to stabilize the L-ascorbic acid and L-glutathione in the tested cosmetic formulation.

METHODS

Verification of Ascorbate Concentration
The total ascorbate in the cosmetic formulation and a competitor product labelled as containing 7.5% L-ascorbic acid was measured using a UV spectrophotometric method. Wavelength scans were performed on a PerkinElmer Lambda 35 Spectrophotometer, (PerkinElmer Corp., Hopkinton, MA) and measurement of ascorbate was taken at 243 nm, the wavelength of maximum absorbance for ascorbic acid under the assay conditions. Ascorbate concentrations in product samples were determined by interpolation; plotting measured values on a concentration curve generated by ascorbic acid standards. The method was verified for all products using ascorbic acid spike recovery assays.

Functional Antioxidant Assay
10 mLs of an 8.8 μM thionin solution prepared in Hanks Balanced Salt Solution (pH 3) was aliquoted to control and test flasks. 250 μl of the study product or the comparator ascorbic acid-containing cosmetic was added to separate thionin-containing